Markets Today(@marketsday) 's Twitter Profile Photo

Natco Pharma board has approved to sell the investment of 15% of shareholding in Joint Limited Liability Company (JLLC) “Nativita”, to M/s. “Pharmasyntez-Nord” Joint Stock Company.

account_circle
mastertrust(@master_trust) 's Twitter Profile Photo

Natco Pharma board has approved to sell the investment of 15% of shareholding in Joint Limited Liability Company (JLLC) “Nativita”, to M/s. “Pharmasyntez-Nord” Joint Stock Company.

account_circle